{
  "description": null,
  "compose": {
    "include": [ {
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "concept": [ {
        "code": "G0008",
        "display": "Administration of influenza virus vaccine"
      }, {
        "code": "G9141",
        "display": "Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family)"
      }, {
        "code": "G9142",
        "display": "Influenza a (h1n1) vaccine, any route of administration"
      }, {
        "code": "Q2033",
        "display": "Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)"
      }, {
        "code": "Q2034",
        "display": "Influenza virus vaccine, split virus, for intramuscular use (agriflu)"
      }, {
        "code": "Q2035",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"
      }, {
        "code": "Q2036",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"
      }, {
        "code": "Q2037",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"
      }, {
        "code": "Q2038",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"
      }, {
        "code": "Q2039",
        "display": "Influenza virus vaccine, not otherwise specified"
      } ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113762.1.4.1234.47.json",
  "package_name": "us.nlm.vsac",
  "date": "2021-11-23T01:02:05-05:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "8",
    "lastUpdated": "2021-11-23T01:02:05.000-05:00"
  },
  "publisher": "BEST System Steward",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: Influenza vaccine HCPCS codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine HCPCS codes.),(Exclusion Criteria: None)",
  "name": "InfluenzaVaccineHCPCSCodesForExposureIdentification",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "expansion": {
    "total": 7,
    "contains": [ {
      "code": "G0008",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Administration of influenza virus vaccine",
      "version": "2023"
    }, {
      "code": "Q2034",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Influenza virus vaccine, split virus, for intramuscular use (agriflu)",
      "version": "2023"
    }, {
      "code": "Q2035",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)",
      "version": "2023"
    }, {
      "code": "Q2036",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)",
      "version": "2023"
    }, {
      "code": "Q2037",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)",
      "version": "2023"
    }, {
      "code": "Q2038",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)",
      "version": "2023"
    }, {
      "code": "Q2039",
      "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
      "display": "Influenza virus vaccine, not otherwise specified",
      "version": "2023"
    } ],
    "timestamp": "2023-11-15T08:08:06-05:00",
    "identifier": "urn:uuid:5f3fe193-3b86-4342-af4e-b72b59c185f1"
  },
  "title": "Influenza vaccine HCPCS codes for exposure identification",
  "package_version": "0.15.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString": "BEST System Author"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2022-12-15"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2021-11-23"
  } ],
  "status": "active",
  "id": "35e28827-b034-4921-99c3-ed5ab6603c3e",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.47",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113762.1.4.1234.47",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20211123"
}